Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
33,057
Sort by:
Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2017
US$ 3,500.00
... Alpha L-Iduronidase (IDUA or EC 3.2.1.76) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
December 2017
48 pages
Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) - Pipeline Review, H2 2017
US$ 2,000.00
... Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
December 2017
30 pages
Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2017
US$ 3,500.00
... Integrin Alpha 7 (ITGA7) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
December 2017
25 pages
Muscarinic Acetylcholine Receptor M2 (CHRM2) - Pipeline Review, H2 2017
US$ 3,500.00
... Muscarinic Acetylcholine Receptor M2 (CHRM2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
December 2017
62 pages
Muscarinic Acetylcholine Receptor M4 (CHRM4) - Pipeline Review, H2 2017
US$ 3,500.00
... Muscarinic Acetylcholine Receptor M4 (CHRM4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
December 2017
65 pages
Somatostatin Receptor Type 4 (SSTR4) - Pipeline Review, H2 2017
US$ 3,500.00
... Somatostatin Receptor Type 4 (SSTR4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
December 2017
37 pages